Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Grand View Research | PRODUCT CODE: 1654142

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1654142

China Companion Animal Health Market Size, Share & Trends Analysis Report By Animal Type, By Product, By Distribution Channel, By End-use, And Segment Forecasts, 2025 - 2030

PUBLISHED:
PAGES: 100 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

China Companion Animal Health Market Growth & Trends:

The China companion animal health market size is anticipated to reach USD 2.36 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 11.22% from 2025 to 2030. The key factors driving the market growth include rising initiatives by key market players, a growing pet population, and high usage of e-commerce channels.

The COVID-19 pandemic had a significant impact on the market in 2020. The adverse effects of the pandemic include supply chain bottlenecks, decreased sales & marketing initiatives, and dampened demand. However, pet ownership and expenditure continued to rise in the country during 2020. Even during the pandemic, online sales of the pet industry showed accelerated growth after an initial slump, as reported by China Daily. Key factors identified for this growth include increasing per capita GDP and pet humanization. For instance, according to the World Bank estimates, per capita GDP in China, in 2020, was USD 10,500, notably greater than the per capita GDP of USD 8,066 in 2015 and USD 4,550 in 2010.

The rising pet population in China is a key factor driving the market growth. The RADII Media reported that in 2020, the popularity of cats as pets was growing rapidly across China. The main reason identified for this trend was cats being relatively low-maintenance pets as compared to pet dogs. As per the Shanghai United Media Group, the preference for exotic and other companion animals is increasing among the young population in the country. Key factors fueling this growth include certain pets needing less upkeep as compared to dogs or horses. For example, geckos or small mammals require much less space, energy, and time from the pet owner as compared to mainstream pets.

Increasing usage of online channels for purchasing pet products is anticipated to propel the market in the coming years. China Daily reported that in 2019, online sales of the pet industry crossed 30 billion Yuan, or about USD 4.3 billion. 70% of the total sales were accounted for by e-commerce giants, such as Tmall and Taobao, as reported at Pet Fair Asia 2020. Key market players leveraged this opportunity to strengthen their market presence. In February 2019, Boehringer Ingelheim, for instance, launched the first-of-its-kind flagship store by a multinational animal health company on Tmall for pet parasiticides. The store was launched to provide customers with a reliable and convenient online purchasing channel for the company's full range of pet parasiticides.

China Companion Animal Health Market Report Highlights:

  • The companion animal medicine segment accounted for the highest share of the market in 2024 owing to the increased awareness about pet health and the high prevalence of diseases in pets
  • Dogs represented the largest segment by animal type for both companion animal medicine as well as diagnostics markets in 2020
  • By indication, non-infectious diseases dominated the China pet medicine as well as diagnostics markets in 2024
  • The growth can be credited to the high awareness about animal health & diseases and increased pet expenditure & pet humanization
  • Global trends, such as the One Health initiative, are expected to further propel awareness about animal health and boost the demand for medicines and diagnostics products for pets
  • In June 2020, the World Bank Group approved a loan of USD 300 million to help strengthen select national and provincial systems in China to lower the risk of zoonoses and other emerging health threats as part of the Emerging Infectious Diseases Prevention, Preparedness and Response Project
Product Code: GVR-4-68039-679-7

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. China Companion Animal Health Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising prevalence of pet diseases
      • 3.2.1.2. Growing uptake of pet insurance
      • 3.2.1.3. Increasing pet population
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of advanced treatment
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenge Analysis
  • 3.3. China Companion Animal Health Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
    • 3.3.3. Regulatory Framework
    • 3.3.4. Pricing Analysis
    • 3.3.5. Product Pipeline Analysis
    • 3.3.6. Estimated Number of pet popultion in China, 2018-2024
    • 3.3.7. COVID-19 Impact Analysis

Chapter 4. China Companion Animal Health Market: Animal type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. China Companion Animal Health Market: Animal type Movement Analysis & Market Share, 2024 & 2030
  • 4.3. Dogs
    • 4.3.1. Dogs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Cats
    • 4.4.1. Cats Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Equine
    • 4.5.1. Equine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Others
    • 4.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. China Companion Animal Health Market: Product Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. China Companion Animal Health Market: Product Movement Analysis & Market Share, 2024 & 2030
  • 5.3. Biologics
    • 5.3.1. Biologics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.2. Vaccines
      • 5.3.2.1. Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.2.2. Modified/ Attenuated Live
        • 5.3.2.2.1. Modified/ Attenuated Live Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.2.3. Inactivated (Killed)
        • 5.3.2.3.1. Inactivated (Killed) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.2.4. Other Vaccines
        • 5.3.2.4.1. Other Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.3. Other Biologics
      • 5.3.3.1. Other Biologics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Pharmaceuticals
    • 5.4.1. Pharmaceuticals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.2. Parasiticides
      • 5.4.2.1. Parasiticides Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.3. Anti-infectives
      • 5.4.3.1. Anti-Infectives Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.4. Anti-Inflammatory
      • 5.4.4.1. Anti-Inflammatory Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.5. Analgesics
      • 5.4.5.1. Analgesics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.6. Others
      • 5.4.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Supplements
    • 5.5.1. Supplements Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Diagnostics
    • 5.6.1. Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. China Companion Animal Health Market: Distribution Channel Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. China Companion Animal Health Market: Distribution Channel Movement Analysis & Market Share, 2024 & 2030
  • 6.3. Retail
    • 6.3.1. Retail Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. E-Commerce
    • 6.4.1. E-Commerce Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Hospital/ Clinic Pharmacies
    • 6.5.1. Hospital/ Clinic Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. China Companion Animal Health Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. China Companion Animal Health Market: End Use Movement Analysis & Market Share, 2024 & 2030
  • 7.3. Hospitals & Clinics
    • 7.3.1. Hospitals & Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. Point-of-Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Others
    • 7.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Company Market Position Analysis/ Heap Map Analysis
  • 8.3. Company Profiles
    • 8.3.1. Boehringer Ingelheim International GmbH
      • 8.3.1.1. Participant's Overview
      • 8.3.1.2. Financial Performance
      • 8.3.1.3. Product Benchmarking
      • 8.3.1.4. Strategic Initiatives
    • 8.3.2. Elanco
      • 8.3.2.1. Participant's Overview
      • 8.3.2.2. Financial Performance
      • 8.3.2.3. Product Benchmarking
      • 8.3.2.4. Strategic Initiatives
    • 8.3.3. Merck & Co., Inc.
      • 8.3.3.1. Participant's Overview
      • 8.3.3.2. Financial Performance
      • 8.3.3.3. Product Benchmarking
      • 8.3.3.4. Strategic Initiatives
    • 8.3.4. Zoetis
      • 8.3.4.1. Participant's Overview
      • 8.3.4.2. Financial Performance
      • 8.3.4.3. Product Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. Ceva
      • 8.3.5.1. Participant's Overview
      • 8.3.5.2. Financial Performance
      • 8.3.5.3. Product Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. Virbac
      • 8.3.6.1. Participant's Overview
      • 8.3.6.2. Financial Performance
      • 8.3.6.3. Product Benchmarking
      • 8.3.6.4. Strategic Initiatives
    • 8.3.7. Bimeda, Inc.
      • 8.3.7.1. Participant's Overview
      • 8.3.7.2. Financial Performance
      • 8.3.7.3. Product Benchmarking
      • 8.3.7.4. Strategic Initiatives
    • 8.3.8. IDEXX Laboratories
      • 8.3.8.1. Participant's Overview
      • 8.3.8.2. Financial Performance
      • 8.3.8.3. Product Benchmarking
      • 8.3.8.4. Strategic Initiatives
    • 8.3.9. Thermo Fisher Scientific
      • 8.3.9.1. Participant's Overview
      • 8.3.9.2. Financial Performance
      • 8.3.9.3. Product Benchmarking
      • 8.3.9.4. Strategic Initiatives
    • 8.3.10. Randox Laboratories
      • 8.3.10.1. Participant's Overview
      • 8.3.10.2. Financial Performance
      • 8.3.10.3. Product Benchmarking
      • 8.3.10.4. Strategic Initiatives
  • 8.4. List of Other Key Players
Product Code: GVR-4-68039-679-7

List of Tables

  • Table 1. List of secondary sources
  • Table 2. China Companion Animal Health market, by animal type , 2018 - 2030 (USD Million)
  • Table 3. China Companion Animal Health market, by Product , 2018 - 2030 (USD Million)
  • Table 4. China Companion Animal Health market, by Biologics, 2018 - 2030 (USD Million)
  • Table 5. China Companion Animal Health market, by Pharmaceuticals, 2018 - 2030 (USD Million)
  • Table 6. China Companion Animal Health market, by Supplements, 2018 - 2030 (USD Million)
  • Table 7. China Companion Animal Health market, by Diagnostics, 2018 - 2030 (USD Million)
  • Table 8. China Companion Animal Health market, by Others , 2018 - 2030 (USD Million)
  • Table 9. China Companion Animal Health market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 10. China Companion Animal Health market, by End Use, 2018 - 2030 (USD Million)
  • Table 11. Participant's overview
  • Table 12. Financial performance
  • Table 13. Product benchmarking
  • Table 14. Strategic Initiatives

List of Figures

  • Fig. 1 Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 QFD modelling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Commodity Flow Analysis
  • Fig. 9 China Companion Animal Health market revenue, 2018 - 2030 (USD Million)
  • Fig. 10 China Companion Animal Health market snapshot
  • Fig. 11 China Companion Animal Health market driver impact
  • Fig. 12 China Companion Animal Health market restraint impact
  • Fig. 13 Porter's 5 Forces Analysis
  • Fig. 14 PESTEL Analysis
  • Fig. 15 China Companion Animal Health market animal type key takeaways (USD Million)
  • Fig. 16 China Companion Animal Health market: animal type movement analysis
  • Fig. 17 China dogs market, 2018 - 2030 (USD Million)
  • Fig. 18 China cats market, 2018 - 2030 (USD Million)
  • Fig. 19 China equine market, 2018 - 2030 (USD Million)
  • Fig. 20 China others market, 2018 - 2030 (USD Million)
  • Fig. 21 China Companion Animal Health product key takeaways (USD Million)
  • Fig. 22 China Companion Animal Health market: product movement analysis
  • Fig. 23 China biologics market, 2018 - 2030 (USD Million)
  • Fig. 24 China vaccines market, 2018 - 2030 (USD Million)
  • Fig. 25 China Modified/ Attenuated Live market, 2018 - 2030 (USD Million)
  • Fig. 26 China Inactivated (Killed) market, 2018 - 2030 (USD Million)
  • Fig. 27 China Other vaccines market, 2018 - 2030 (USD Million)
  • Fig. 28 China other biologics market, 2018 - 2030 (USD Million)
  • Fig. 29 China pharamceuticals market, 2018 - 2030 (USD Million)
  • Fig. 30 China parasiticides market, 2018 - 2030 (USD Million)
  • Fig. 31 China Anti-infectives market, 2018 - 2030 (USD Million)
  • Fig. 32 China Anti-inflammatory market, 2018 - 2030 (USD Million)
  • Fig. 33 China Analgesics market, 2018 - 2030 (USD Million)
  • Fig. 34 China supplements market, 2018 - 2030 (USD Million)
  • Fig. 35 China diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 36 China others market, 2018 - 2030 (USD Million)
  • Fig. 37 China Companion Animal Health market distribution channel key takeaways (USD Million)
  • Fig. 38 China Companion Animal Health market: distribution channel movement analysis
  • Fig. 39 China retail market, 2018 - 2030 (USD Million)
  • Fig. 40 China e-commerce market, 2018 - 2030 (USD Million)
  • Fig. 41 China Hospital/ Clinic Pharmacies market, 2018 - 2030 (USD Million)
  • Fig. 42 China Companion Animal Health market end use key takeaways (USD Million)
  • Fig. 43 China Companion Animal Health market: end use movement analysis
  • Fig. 44 China Hospitals & Clinics market, 2018 - 2030 (USD Million)
  • Fig. 45 China Point-of-Care market, 2018 - 2030 (USD Million)
  • Fig. 46 China others market, 2018 - 2030 (USD Million)
  • Fig. 47 Market participant categorization
  • Fig. 48 Heat map analysis/Company market position analysis
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!